Latest Profitability News

AMCIL Limited posted a half-year profit of $3.6 million, down 12.6%, yet its portfolio outperformed the S&P/ASX 200 with an 8.7% return. The company declared a steady interim dividend amid cautious market conditions.

Respiri Limited reports a standout December quarter marked by a 67% surge in patient program enrolments and robust revenue growth, bolstered by strategic acquisition synergies from Orb Health. The company is poised for further expansion in 2025 amid promising contract negotiations and evolving US healthcare reimbursement policies.

Coventry Group reports a slight dip in H1 FY25 sales but manages a modest EBITDA increase, buoyed by a successful ERP upgrade and strategic growth initiatives.

Barton Gold Holdings reports a robust December quarter marked by a $5 million gold sale, extensive drilling at Tunkillia and Tarcoola projects, and a strong cash position heading into 2025.

Kogan.com reports robust first-half FY25 results with double-digit growth in sales and profits, driven by strategic marketing and a major digital upgrade at Mighty Ape despite initial setbacks.

Pacific Smiles Group reports robust patient fee growth of over 9% year-on-year and reaffirms FY25 guidance, while announcing a CFO change as Genesis Capital solidifies its majority stake.

BSA Limited reported a robust Q2 FY2025 with revenue up 10.7% and EBITDA surging 31.5%, underpinned by a key contract extension with nbn. The company has upgraded its full-year EBITDA guidance, signaling confidence in sustained profitability.

Fertoz Limited reports solid Q4 2024 sales despite Canadian permit delays and plans a strategic rebrand to Canadian Phosphate Limited to align with its growth ambitions.

Synlait Milk Limited projects a return to profitability in HY25 with EBITDA guidance between $58 million and $63 million, underpinned by strategic growth and cost control. The company also enhances its financial incentives to secure South Island milk supply for the next three seasons.

KMD Brands reports improving sales in direct-to-consumer channels for FY25’s first five months, offset by ongoing wholesale challenges and a forecasted dip in EBITDA.

Michael Hill International reports a 24% drop in comparable EBIT for FY25H1 amid challenging conditions, yet margin improvements and digital growth offer a silver lining.

Biome Australia Limited has expanded its distribution footprint to over 6,000 health retail and practitioner locations, marking a 20% increase in six months and advancing toward its Vision 27 target of 8,000 sites by FY27.